Do urinary mast cell mediators predict immune response to BCG in patients with primary high-grade non-muscle invasive bladder cancer?

Muhammed Fatih Simsekoglu İslim Kaleler Bülent Önal Çetin Demirdağ Sinharib Citgez Ezel Uslu Ahmet Erozenci Zubeyr Talat

Published in: International journal of clinical practice (2021)

Our study is the first to identify the changes in mast cell mediators with the onset of immunotherapy and in presence of bladder cancer. However, these mediators cannot predict patients' response to immunotherapy.

Keyphrases

muscle invasive bladder cancer
high grade
immune response
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
inflammatory response